Saturday, February 21, 2026
18.4 C
Bengaluru

Interview with Salil Kallianpur

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur  with Anup Soans, Editor – MedicinMan

“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”

2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram

Patient-centricity begins with moving from talking about the patient to talking to the patient 

3. The Corporate Halo Effect by Vivek Hattangadi

How a great corporate brand elevates a company’s products in the minds of doctors and patients

4. For a Positive Attitude, Clean Your Mind’s Windows  by Asheesh Kumar Patel

A bad attitude is a learned behavior and can be unlearned when we discover it’s source

5. The Three Transformations for Leadership  by Srinivasan Athmanathan

Three key professional traits that every successful leader must possess

6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian 

A corporate saga with valuable lessons for professionals of all backgrounds

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img